A case of haemorrhagic myositis with concurrent anti-Ro52 and anti-NXP-2 antibodies treated with plasmapheresis

Simple item page
dc.contributor.authorBrown, Z.R.
dc.contributor.authorThomas, J.S.
dc.contributor.authorLimaye, V.
dc.date.issued2020
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityZoe R Brown, Josephine S Thomas, Vidya Limaye
dc.identifier.citationRheumatology, 2020; 59(3):682-684
dc.identifier.doi10.1093/rheumatology/kez365
dc.identifier.issn1462-0324
dc.identifier.issn1462-0332
dc.identifier.orcidThomas, J.S. [0000-0001-8124-5920]
dc.identifier.orcidLimaye, V. [0000-0002-8142-9532]
dc.identifier.urihttp://hdl.handle.net/2440/126501
dc.language.isoen
dc.publisherOxford University Press
dc.rights© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.
dc.source.urihttps://doi.org/10.1093/rheumatology/kez365
dc.subjectHumans
dc.subjectMyositis
dc.subjectRibonucleoproteins
dc.subjectDNA-Binding Proteins
dc.subjectAutoantibodies
dc.subjectTreatment Outcome
dc.subjectPlasmapheresis
dc.subjectAdult
dc.subjectMale
dc.subjectAdenosine Triphosphatases
dc.titleA case of haemorrhagic myositis with concurrent anti-Ro52 and anti-NXP-2 antibodies treated with plasmapheresis
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medical Sciences publications